These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16716103)

  • 1. Antithrombotic therapy in heart failure.
    Verheugt FW
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):277-8. PubMed ID: 16716103
    [No Abstract]   [Full Text] [Related]  

  • 2. Systolic heart failure: a prothrombotic state.
    de Peuter OR; Kok WE; Torp-Pedersen C; Büller HR; Kamphuisen PW
    Semin Thromb Hemost; 2009 Jul; 35(5):497-504. PubMed ID: 19739040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ; Spinler SA
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 6. What do we know about anticoagulation in patients with heart failure?
    Ahnert AM; Freudenberger RS
    Curr Opin Cardiol; 2008 May; 23(3):228-32. PubMed ID: 18382211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet agents and arterial thrombosis.
    Billett HH
    Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy for heart failure in sinus rhythm.
    Subramaniam V; Davis RC; Shantsila E; Lip GY
    Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulant, antiplatelet agents].
    Ishikawa K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():647-53. PubMed ID: 12735045
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 11. Warfarin and aspirin for prevention of IHD.
    Zamorski MA
    J Fam Pract; 1998 May; 46(5):358-9. PubMed ID: 9597990
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
    Testa L; Zoccai GB; Porto I; Trotta G; Agostoni P; Andreotti F; Crea F
    Am J Cardiol; 2007 Jun; 99(12):1637-42. PubMed ID: 17560866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient.
    Smith DA
    Cardiology; 2008; 111(3):158-60. PubMed ID: 18434718
    [No Abstract]   [Full Text] [Related]  

  • 14. Testing a no-warfarin heart valve.
    Harv Heart Lett; 2006 Apr; 16(8):7. PubMed ID: 19685564
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimal antithrombotic therapy in patients receiving long-term oral anticoagulation requiring percutaneous coronary intervention: "triple therapy" or "triple threat".
    Tapp LD; Lip GYH; Lane DA
    Chest; 2011 Feb; 139(2):240-243. PubMed ID: 21285051
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulation and heart failure.
    Graham SP
    Curr Cardiol Rep; 2001 Jan; 3(1):72-7. PubMed ID: 11139802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet and anticoagulant therapy in patients with advanced heart failure.
    Lip GY; Chung I
    Thromb Res; 2005; 116(4):275-7. PubMed ID: 16038710
    [No Abstract]   [Full Text] [Related]  

  • 20. Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR.
    Jackson SL; Peterson GM; Bereznicki LR
    Am Heart J; 2005 Jan; 149(1):e3; author reply e4. PubMed ID: 15660026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.